14.14
0.14 (1.00%)
| Penutupan Terdahulu | 14.00 |
| Buka | 13.91 |
| Jumlah Dagangan | 661,775 |
| Purata Dagangan (3B) | 693,209 |
| Modal Pasaran | 1,812,154,112 |
| Harga / Jualan (P/S) | 3.22 |
| Harga / Buku (P/B) | 2.32 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Nov 2024 |
| Margin Keuntungan | -12.07% |
| Margin Operasi (TTM) | -8.39% |
| EPS Cair (TTM) | -0.610 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 10.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 66.75% |
| Nisbah Semasa (MRQ) | 1.99 |
| Aliran Tunai Operasi (OCF TTM) | 15.01 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 9.09 M |
| Pulangan Atas Aset (ROA TTM) | -2.76% |
| Pulangan Atas Ekuiti (ROE TTM) | -8.38% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Bercampur |
| Diagnostics & Research (Global) | Bercampur | Bercampur | |
| Stok | NeoGenomics, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 4.0 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -0.50 |
|
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 1.21% |
| % Dimiliki oleh Institusi | 99.79% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 22.00 (Jefferies, 55.59%) | Beli |
| Median | 19.00 (34.37%) | |
| Rendah | 18.00 (Benchmark, 27.30%) | Beli |
| Purata | 19.50 (37.91%) | |
| Jumlah | 3 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 16.86 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| B of A Securities | 13 Dec 2024 | 19.00 (34.37%) | Pegang | 17.73 |
| Jefferies | 10 Dec 2024 | 22.00 (55.59%) | Beli | 18.43 |
| Needham | 06 Nov 2024 | 19.00 (34.37%) | Beli | 15.46 |
| 25 Sep 2024 | 19.00 (34.37%) | Beli | 14.96 | |
| Benchmark | 24 Sep 2024 | 18.00 (27.30%) | Beli | 15.80 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |